Clinical Trial Update: Effectiveness and Safety of MMSCs for Enhancing Hematopoietic Recovery and Prophylaxis of Neutropenic Enterocolitis [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial assessing the safety and effectiveness of mesenchymal cell therapy (MMSCs) to enhance hematopoietic recovery and prevent neutropenic enterocolit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myeloablative Chemotherapy-induced Bone Marrow Aplasia
• Neutropenic Enterocolitis

Drugs mentioned

• MMSCs

Snippet

Sponsor: Burnasyan Federal Medical Biophysical Center | Conditions: Neutropenic Enterocolitis, Myeloablative Chemotherapy Induced Bone Marrow Aplasia | Phase 1, Phase 2 | Status: UNKNOWN